Please select a country
- Česká republika
- CeramTec GmbH
- CeramTec-ETEC GmbH
- Emil Müller GmbH
Dr. Ulf-D. Zimmermann was born in Elze/Hanover, Germany. He studied Management Engineering at the Technical University in Berlin. While obtaining his doctorate in Engineering, he worked as a scientific assistant at the Technical University. From 1980 to 1990 Dr. Ulf-D. Zimmermann worked for Flick KGaA in Ratingen; first as an assistant to the Executive Board, then later as the Managing Director of Eichener Maschinenfabrik in Siegerland and Conti Systembau in Ratingen. In 1990 he took over the position of Managing Director of the Diesel Engines Division of KHD AG in Cologne. From there Dr. Ulf-D. Zimmermann went on to become Division Manager of GEA AG Bochum in 1996, where he headed up WestfaliaSurge Oelde/Chicago. On April 1, 2001 he was appointed to the Executive Board of Dynamit Nobel AG Troisdorf. He simultaneously accepted the appointment to Chairman of the Executive Board of CeramTec, which belonged to the Dynamit Nobel Group at that time. Following the acquisition by the Rockwood Group in August 2004, Dr. Ulf-D. Zimmermann also took over the role of Division President of this company headquartered in Princeton, NJ, USA. In 2013 Rockwood decided to reposition its business and sold the majority of its portfolio including CeramTec. Dr. Ulf-D. Zimmermann organized this process actively including the sale to Cinven.
Member of the Executive Board (Finance)
Effective 1 October 2014, Dominique Janbon was appointed to the Executice Board of the CeramTec Group as Chief Financial Officer. Mr. Janbon joins from medical technology company Gambro AB, where he was CFO and Senior Vice President since 2012. During his time at Gambro he was part of the senior management team which implemented a new growth strategy for the company. In his role, he contributed significantly to the successful transformation of the company and later to the US$ 4bn sale of the company to Baxter. Dominique Janbon previously held senior positions in finance and commercial development at global pharmaceutical companies Amgen International and Sanofi S.A. Dominique Janbon holds a Master of Sciences in Accounting and Finance from the London School of Economics and a Master degree in Economics, Management and Finance from the Institut d’Etudes Politiques de Paris. He is a French national.
Member of the Executive Board (COO Medical Applications Segment)
Dr. Hadi Saleh was appointed to CeramTec’s Executive Board on July 1, 2015 and is responsible for the Medical Applications Segment as its Chief Operating Officer. Dr. Saleh worked in the medical technology sector, where as Senior Vice President of Biomet Inc. and President of Biomet International he was previously responsible for all Bionet product lines worldwide outside of the US and Europe. In addition, he played a leading role in the Zimmer Holdings acquisition of Bioment Inc. this June. Since 2001, Dr. Saleh has held a number of positions at Biomet, first at Biomet Germany, then Biomet Europe and finally at the parent company, Biomet Inc. in Warsaw, IN in the United States. Prior to this he studied and earned his doctorate at the universities in Frankfurt am Main and Mainz, worked as an orthopedist at St. Josef’s Hospital in Wiesbaden and at the University Clinic in Heidelberg and was a Senior Consultant at GAIA in Hamburg.
Please click on the button “Contacts” to the right, to get a list with the personal and direct responsible contacts within the CeramTec Group.